FTXHvsTMEDETF Comparison
First Trust Nasdaq Pharmaceuticals ETF (FTXH) and T. Rowe Price Health Care ETF (TMED) belong to the same industry segment: US Health Care. Both ETFs have the same top 3 sector exposures: and Health Care. FTXH is more expensive with a Total Expense Ratio (TER) of 0.6%, versus 0.44% for TMED. FTXH is up 9.46% year-to-date (YTD) with +$10M in YTD flows. TMED performs worse with 6.93% YTD performance, and +$4M in YTD flows. Run a side-by-side ETF comparison of FTXH and TMED below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
FTXH vs TMED performance and flow charts
Performance
Cumulative Flows
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | FTXH TMED | +4.89%+5.32% | +6.69%+7.29% | +9.46%+6.93% | +38.27%+27.94% | +43.75%n/a | +46.87%n/a |
| Flows | FTXH TMED | -$2M+$2M | +$3M+$2M | +$10M+$4M | +$7M+$18M | -$3M- | +$5M- |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | FTXH TMED | +17.83%+21.78% | +17.06%+18.19% | +16.29%n/a | +15.91%n/a |
| Max drawdown | FTXH TMED | -4.47%-6.52% | -7.50%-11.09% | -19.32%n/a | -19.32%n/a |
| Max drawdown duration | FTXH TMED | 32d27d | 99d125d | 393dn/a | 393dn/a |
FTXH | TMED | |
Last sale 6/12/2026 at 1:30 PM | $36.01 | $31.72 |
| Previous close 06/11/2026 | $36.09 | $31.77 |
| Consolidated volume 06/11/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Create an account to view replication metrics
FTXH | TMED | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
FTXH | TMED | |
|---|---|---|
| Last price | $36.01 | $31.72 |
| 1D performance | -0.21% | -0.15% |
| AuM | $34.18 M | $22.22 M |
| E/R | 0.6% | 0.44% |
FTXH | TMED | |
|---|---|---|
| Management strategy | Passive | Active |
| Provider | First Trust | T. Rowe Price |
| Benchmark | NASDAQ US Smart Pharmaceuticals Index | - |
| N° of holdings | 47 | 74 |
| Asset class | Equities | - |
| Trailing 12m distribution yield | Join | Join |
| Inception date | September 20, 2016 | June 11, 2025 |
| ESG | No | No |
Countries
Sectors
Diversification
Total weight of top 15 holdings out of 15
Total weight of top 15 holdings out of 15
